Chemoinformaics analysis of (S)-N-(3,4-Dimethoxybenzyl)-1-phenylethanamine-
| Molecular Weight | 271.36 | nRot | 6 |
| Heavy Atom Molecular Weight | 250.192 | nRig | 12 |
| Exact Molecular Weight | 271.157 | nRing | 2 |
| Solubility: LogS | -2.194 | nHRing | 0 |
| Solubility: LogP | 2.639 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 41 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 20 | No. of Aromatic Carbocycles | 2 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 21 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 17 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 12 |
| nHA | 3 | APOL | 45.0967 |
| nHD | 1 | BPOL | 25.1093 |
| QED | 0.871 |
| Synth | 2.003 |
| Natural Product Likeliness | -0.69 |
| NR-PPAR-gamma | 0.001 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.829 |
| Pgp-sub | 0.055 |
| HIA | 0.004 |
| CACO-2 | -4.532 |
| MDCK | 0.0000187 |
| BBB | 0.724 |
| PPB | 0.776694 |
| VDSS | 2.289 |
| FU | 0.0998543 |
| CYP1A2-inh | 0.744 |
| CYP1A2-sub | 0.941 |
| CYP2c19-inh | 0.869 |
| CYP2c19-sub | 0.92 |
| CYP2c9-inh | 0.05 |
| CYP2c9-sub | 0.631 |
| CYP2d6-inh | 0.971 |
| CYP2d6-sub | 0.93 |
| CYP3a4-inh | 0.761 |
| CYP3a4-sub | 0.683 |
| CL | 7.8 |
| T12 | 0.685 |
| hERG | 0.106 |
| Ames | 0.087 |
| ROA | 0.672 |
| SkinSen | 0.076 |
| Carcinogencity | 0.045 |
| EI | 0.02 |
| Respiratory | 0.062 |
| NR-Aromatase | 0.012 |
| Antiviral | No |
| Prediction | 0.709815 |